Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film
Go back to Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film| (NASDAQ: AQST) | Delayed: 4.66 -0.16 (3.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.82 | 52 Week High | $ | |||
| Open | $5.00 | 52 Week Low | $ | |||
| Day High | $5.00 | P/E | N/A | |||
| Day Low | $4.62 | EPS | $ | |||
| Volume | 2,529,929 | |||||

